Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neurosurgery

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    October 2018
  1. VANDERSTRAETEN B, Goddeeris B, Vandecasteele K, van Eijkeren M, et al
    Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical Preference.
    Int J Radiat Oncol Biol Phys. 2018;102:443-450.
    PubMed     Text format     Abstract available


  2. MEIER RM, Bloch DA, Cotrutz C, Beckman AC, et al
    Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.
    Int J Radiat Oncol Biol Phys. 2018;102:296-303.
    PubMed     Text format     Abstract available


  3. PALACIOS MA, Bohoudi O, Bruynzeel AME, van Sorsen de Koste JR, et al
    Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Int J Radiat Oncol Biol Phys. 2018;102:426-433.
    PubMed     Text format     Abstract available


    August 2018
  4. GHIA AJ, Guha-Thakurta N, Hess K, Yang JN, et al
    Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously unirradiated metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2018 Aug 9. pii: S0360-3016(18)33524.
    PubMed     Text format     Abstract available


    March 2018
  5. MINNITI G, Soltys SG, Halasz LM, Breneman JC, et al
    Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain.
    Int J Radiat Oncol Biol Phys. 2018;100:535-538.
    PubMed     Text format    


  6. TEKATLI H, Duijm M, Oomen-de Hoop E, Verbakel W, et al
    Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2018;100:738-747.
    PubMed     Text format     Abstract available


  7. GALLE JO, Long DE, Lautenschlaeger T, Zellars RC, et al
    Effects of Proton Center Closure on Pediatric Case Volume and Resident Education at an Academic Cancer Center.
    Int J Radiat Oncol Biol Phys. 2018;100:710-718.
    PubMed     Text format     Abstract available


  8. NABAVIZADEH N, Waller JG, Fain R 3rd, Chen Y, et al
    Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Int J Radiat Oncol Biol Phys. 2018;100:577-585.
    PubMed     Text format     Abstract available


    January 2018
  9. SURESH K, Owen D, Bazzi L, Jackson W, et al
    Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:131-137.
    PubMed     Text format     Abstract available


  10. ITO K, Shimizuguchi T, Nihei K, Furuya T, et al
    Patterns of Intraosseous Recurrence After Stereotactic Body Radiation Therapy for Coxal Bone Metastasis.
    Int J Radiat Oncol Biol Phys. 2018;100:159-161.
    PubMed     Text format     Abstract available


  11. SAPIR E, Tao Y, Schipper MJ, Bazzi L, et al
    Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:122-130.
    PubMed     Text format     Abstract available


    December 2017
  12. BERNARD V, Bishop AJ, Allen PK, Amini B, et al
    Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
    Int J Radiat Oncol Biol Phys. 2017;99:1207-1215.
    PubMed     Text format     Abstract available


  13. KELLER A, Dore M, Cebula H, Thillays F, et al
    Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:1179-1189.
    PubMed     Text format     Abstract available


    November 2017
  14. JOO JH, Park JH, Kim JC, Yu CS, et al
    Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:876-883.
    PubMed     Text format     Abstract available


  15. KOONTZ BF
    Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: The Hunt for the Silver Bullet.
    Int J Radiat Oncol Biol Phys. 2017;99:761-763.
    PubMed     Text format    


  16. KUMAR S, Feddock J, Li X, Shearer AJ, et al
    Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:652-659.
    PubMed     Text format     Abstract available


    October 2017
  17. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
    Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:459-467.
    PubMed     Text format     Abstract available


  18. MCPARTLIN A, Swaminath A, Wang R, Pintilie M, et al
    Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:388-395.
    PubMed     Text format     Abstract available


  19. BAHIG H, Campeau MP, Lapointe A, Bedwani S, et al
    Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2017;99:334-343.
    PubMed     Text format     Abstract available


    September 2017
  20. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
    Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
    PubMed     Text format     Abstract available


  21. YAMAMOTO M, Serizawa T, Higuchi Y, Sato Y, et al
    A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores
    Int J Radiat Oncol Biol Phys. 2017;99:31-40.
    PubMed     Text format     Abstract available


  22. WILLIAMS NL, Wuthrick EJ, Kim H, Palmer JD, et al
    Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:22-30.
    PubMed     Text format     Abstract available


  23. WU CC, Chaudhary KR, Na YH, Welch D, et al
    Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.
    Int J Radiat Oncol Biol Phys. 2017;99:191-201.
    PubMed     Text format     Abstract available


  24. CHOI CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, et al
    Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2017;99:16-21.
    PubMed     Text format     Abstract available


  25. LO CH, Liu MY, Lee MS, Yang JF, et al
    Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:145-152.
    PubMed     Text format     Abstract available


    August 2017
  26. CHURILLA TM, Ballman KV, Brown PD, Twohy EL, et al
    Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2017 Aug 5. pii: S0360-3016(17)33691.
    PubMed     Text format     Abstract available


  27. WERNICKE AG, Hirschfeld CB, Smith AW, Taube S, et al
    Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2017;98:1059-1068.
    PubMed     Text format     Abstract available


  28. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
    Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
    Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
    PubMed     Text format     Abstract available


  29. KOTECHA R, Miller JA, Modugula S, Barnett GH, et al
    Stereotactic Radiosurgery for Trigeminal Neuralgia Improves Patient-Reported Quality of Life and Reduces Depression.
    Int J Radiat Oncol Biol Phys. 2017;98:1078-1086.
    PubMed     Text format     Abstract available


    July 2017
  30. CHEN L, Shen C, Redmond KJ, Page BR, et al
    Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:939-947.
    PubMed     Text format     Abstract available


  31. PRESS RH, Boselli DM, Symanowski JT, Lankford SP, et al
    External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:632-638.
    PubMed     Text format     Abstract available


  32. CHEN H, Senan S, Nossent EJ, Boldt RG, et al
    Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2017;98:622-631.
    PubMed     Text format     Abstract available


  33. RUSCHIN M, Sahgal A, Tseng CL, Sonier M, et al
    Dosimetric Impact of Using a Virtual Couch Shift for Online Correction of Setup Errors for Brain Patients on an Integrated High-Field Magnetic Resonance Imaging Linear Accelerator.
    Int J Radiat Oncol Biol Phys. 2017;98:699-708.
    PubMed     Text format     Abstract available


  34. SU TS, Liang P, Liang J, Lu HZ, et al
    Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017;98:639-646.
    PubMed     Text format     Abstract available


  35. RIEBER J, Abbassi-Senger N, Adebahr S, Andratschke N, et al
    Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
    Int J Radiat Oncol Biol Phys. 2017;98:511-520.
    PubMed     Text format     Abstract available


  36. CORKUM MT
    Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
    Int J Radiat Oncol Biol Phys. 2017;98:492-493.
    PubMed     Text format    


    June 2017
  37. CLARKE J, Neil E, Terziev R, Gutin P, et al
    Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Int J Radiat Oncol Biol Phys. 2017 Jun 30. pii: S0360-3016(17)33549.
    PubMed     Text format     Abstract available


  38. SHENG Y, Li T, Lee WR, Yin FF, et al
    Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:473-480.
    PubMed     Text format     Abstract available


  39. HELOU J, Thibault I, Poon I, Chiang A, et al
    Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Int J Radiat Oncol Biol Phys. 2017;98:419-427.
    PubMed     Text format     Abstract available


    May 2017
  40. RAHIMI A, Thomas K, Spangler A, Rao R, et al
    Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2017;98:196-205.
    PubMed     Text format     Abstract available


  41. FARRIS M, McTyre ER, Cramer CK, Hughes R, et al
    Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Int J Radiat Oncol Biol Phys. 2017;98:131-141.
    PubMed     Text format     Abstract available


  42. POLLOM EL, Fujimoto D, Wynne J, Seiger K, et al
    Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Int J Radiat Oncol Biol Phys. 2017;98:123-130.
    PubMed     Text format     Abstract available


  43. WANG CJ, Christie A, Lin MH, Jung M, et al
    Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:91-100.
    PubMed     Text format     Abstract available


  44. CHEN AM, Yoshizaki T, Velez MA, Mikaeilian AG, et al
    Tolerance of the Brachial Plexus to High-Dose Reirradiation.
    Int J Radiat Oncol Biol Phys. 2017;98:83-90.
    PubMed     Text format     Abstract available


  45. YAZICI G, Kiratli H, Ozyigit G, Sari SY, et al
    Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
    Int J Radiat Oncol Biol Phys. 2017;98:152-158.
    PubMed     Text format     Abstract available


  46. HRYCUSHKO BA, Chopra R, Sayre JW, Richardson JA, et al
    Local Hypothermia as a Radioprotector of the Rectal Wall During Prostate Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:75-82.
    PubMed     Text format     Abstract available


  47. RITTER TA, Matuszak M, Chetty IJ, Mayo CS, et al
    Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials.
    Int J Radiat Oncol Biol Phys. 2017;98:34-36.
    PubMed     Text format    


  48. COOPER JS
    Radiation Therapy Followed by Ipilimumab Is Appropriate.
    Int J Radiat Oncol Biol Phys. 2017;98:13.
    PubMed     Text format    


    April 2017
  49. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Text format     Abstract available


  50. VELEC M, Haddad CR, Craig T, Wang L, et al
    Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017;97:939-946.
    PubMed     Text format     Abstract available


  51. MANNINA EM, Cardenes HR, Lasley FD, Goodman B, et al
    Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes.
    Int J Radiat Oncol Biol Phys. 2017;97:931-938.
    PubMed     Text format     Abstract available


  52. POLLOCK BE, Link MJ, Stafford SL, Parney IF, et al
    The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:919-923.
    PubMed     Text format     Abstract available


  53. MCCOWAN PM, Asuni G, Van Uytven E, VanBeek T, et al
    Clinical Implementation of a Model-Based In Vivo Dose Verification System for Stereotactic Body Radiation Therapy-Volumetric Modulated Arc Therapy Treatments Using the Electronic Portal Imaging Device.
    Int J Radiat Oncol Biol Phys. 2017;97:1077-1084.
    PubMed     Text format     Abstract available


    March 2017
  54. CHAN M, Grehn M, Cremers F, Siebert FA, et al
    Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:839-848.
    PubMed     Text format     Abstract available


  55. VERMA V, Shostrom VK, Zhen W, Zhang M, et al
    Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (>/=5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:778-785.
    PubMed     Text format     Abstract available


  56. GUCKENBERGER M
    SBRT in eight fractions.
    Int J Radiat Oncol Biol Phys. 2017;97:653.
    PubMed     Text format    


  57. ZENG J, Lo SS
    SBRT in five fractions.
    Int J Radiat Oncol Biol Phys. 2017;97:652-653.
    PubMed     Text format    


  58. PALMA DA
    An Ultracentral Lung Tumor.
    Int J Radiat Oncol Biol Phys. 2017;97:651.
    PubMed     Text format    


  59. SHAVERDIAN N, Verruttipong D, Wang PC, Kishan AU, et al
    Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:516-525.
    PubMed     Text format     Abstract available


  60. MELOTEK JM, Chmura SJ
    Oligometastasis-Directed Ablative Therapy: A Clinical Trial Question.
    Int J Radiat Oncol Biol Phys. 2017;97:448.
    PubMed     Text format    


  61. FANG P
    Internal Mammary Misfortune.
    Int J Radiat Oncol Biol Phys. 2017;97:447.
    PubMed     Text format    


    February 2017
  62. PETRELLI F, Comito T, Ghidini A, Torri V, et al
    Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:313-322.
    PubMed     Text format     Abstract available


  63. GOROVETS D, Ayala-Peacock D, Tybor DJ, Rava P, et al
    Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:246-253.
    PubMed     Text format     Abstract available


  64. BOYCE-FAPPIANO D, Elibe E, Schultz L, Ryu S, et al
    Analysis of the Factors Contributing to Vertebral Compression Fractures After Spine Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2017;97:236-245.
    PubMed     Text format     Abstract available


    January 2017
  65. MEHRABIAN H, Desmond KL, Chavez S, Bailey C, et al
    Water Exchange Rate Constant as a Biomarker of Treatment Efficacy in Patients With Brain Metastases Undergoing Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2017 Jan 10. pii: S0360-3016(17)30020.
    PubMed     Text format     Abstract available


  66. GIULIANI M, Hope A, Guckenberger M, Mantel F, et al
    Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 9. pii: S0360-3016(17)30023.
    PubMed     Text format     Abstract available


  67. REDMOND KJ, Robertson S, Lo SS, Soltys SG, et al
    Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine.
    Int J Radiat Oncol Biol Phys. 2017;97:64-74.
    PubMed     Text format     Abstract available


  68. AL-HALLAQ HA, Chmura SJ, Salama JK, Lowenstein JR, et al
    Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:155-163.
    PubMed     Text format     Abstract available


  69. THIBAULT I, Whyne CM, Zhou S, Campbell M, et al
    Volume of Lytic Vertebral Body Metastatic Disease Quantified Using Computed Tomography-Based Image Segmentation Predicts Fracture Risk After Spine Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:75-81.
    PubMed     Text format     Abstract available


  70. LEEMAN JE, Rimner A, Montecalvo J, Hsu M, et al
    Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:138-145.
    PubMed     Text format     Abstract available


  71. SCHULER E, Trovati S, King G, Lartey F, et al
    Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator.
    Int J Radiat Oncol Biol Phys. 2017;97:195-203.
    PubMed     Text format     Abstract available


  72. POSNER M, Gupta V
    Robotic Surgery plus Chemo-Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:4-5.
    PubMed     Text format    


    December 2016
  73. BROOKS ED, Sun B, Zhao L, Komaki R, et al
    Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Dec 21. pii: S0360-3016(16)33596.
    PubMed     Text format     Abstract available


  74. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96:1011-1020.
    PubMed     Text format     Abstract available


  75. VIDETIC GM
    Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016;96:927-930.
    PubMed     Text format    


    November 2016
  76. VERMA V, Simone CB 2nd, Allen PK, Gajjar SR, et al
    Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Nov 2. pii: S0360-3016(16)33392.
    PubMed     Text format     Abstract available


  77. DU S, Lockamy V, Zhou L, Xue C, et al
    Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:529-37.
    PubMed     Text format     Abstract available


    October 2016
  78. MUI WH, Lam TC, Wong FC, Sze WK, et al
    Survival Analysis of Malignant Epidural Spinal Cord Compression After Palliative Radiation Therapy Using Tokuhashi Scoring System and the Impact of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  79. LEE VH, Lam TW, Ng SC, Szeto MH, et al
    Effect of Titanium Hardware on Radiation Dosimetry in Postoperative Proton Versus Photon Spinal Stereotactic Body Radiation Therapy After Surgical Decompression for Spinal Cord Compression.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  80. SAADATMAND HJ, Wu CC, Lesser J, Isaacson SR, et al
    Improved Outcomes in Acoustic Neuroma Patients Receiving Stereotactic Radiosurgery from a Single Neurosurgeon at a High-Volume Institution.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  81. TAUBE S, Smith AW, Hirschfeld C, Nedialkova L, et al
    Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  82. GESTAUT MM, Thawani N, Kim S, Gutti VR, et al
    Spine Stereotactic Ablative Body Radiation Therapy (SABR) With Volumetric Modulated Arc Therapy (VMAT) for Vertebral Metastases With and Without Metastatic Spinal Cord Compression (MSCC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  83. PENNINGTON JD, Kishan AU, Chen AM
    Simulated Consult and Treatment of Malignant Epidural Spinal Cord Compression Improves Trainee Confidence and Knowledge Prior to Taking Radiation Oncology Call.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    September 2016
  84. VERMA V, McMillan MT, Grover S, Simone CB 2nd, et al
    Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (>/=5 Centimeter) Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Sep 29. pii: S0360-3016(16)33247.
    PubMed     Text format     Abstract available


  85. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
    Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
    PubMed     Text format     Abstract available


    August 2016
  86. HEPEL JT, Leonard KL, Safran H, Ng T, et al
    Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2016 Aug 31. pii: S0360-3016(16)33147.
    PubMed     Text format     Abstract available


  87. BI N, Shedden K, Zheng X, Kong FM, et al
    Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;95:1378-90.
    PubMed     Text format     Abstract available


    July 2016
  88. LING DC, Vargo JA, Ferris RL, Ohr J, et al
    Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:973-80.
    PubMed     Text format     Abstract available


  89. KOTECHA R, Djemil T, Tendulkar RD, Reddy CA, et al
    Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;95:960-4.
    PubMed     Text format     Abstract available


    June 2016
  90. ROSSI MM, Peulen HM, Belderbos JS, Sonke JJ, et al
    Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:835-43.
    PubMed     Text format     Abstract available


  91. MULDERMANS JL, Romak LB, Kwon ED, Park SS, et al
    Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:696-702.
    PubMed     Text format     Abstract available


    April 2016
  92. PEULEN H, Mantel F, Guckenberger M, Belderbos J, et al
    Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 12. pii: S0360-3016(16)30106.
    PubMed     Text format     Abstract available


    March 2016
  93. MINNITI G, Scaringi C, Paolini S, Lanzetta G, et al
    Single-Fraction Versus Multifraction (3 x 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
    Int J Radiat Oncol Biol Phys. 2016 Mar 19. pii: S0360-3016(16)00325.
    PubMed     Text format     Abstract available


    February 2016
  94. SONG C, Hong BJ, Bok S, Lee CJ, et al
    Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Int J Radiat Oncol Biol Phys. 2016 Feb 13. pii: S0360-3016(16)00138.
    PubMed     Text format     Abstract available


  95. SHEN CJ, Kummerlowe MN, Redmond KJ, Rigamonti D, et al
    Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2016 Feb 9. pii: S0360-3016(16)00107.
    PubMed     Text format     Abstract available


  96. MAGNUSON WJ, Yeung JT, Guillod PD, Gettinger SN, et al
    Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016 Feb 2. pii: S0360-3016(16)00058.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neurosurgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: